de Vries, Johan (2019) An overview: Staphylococcus aureus phage therapy. Bachelor's Thesis, Life Science and Technology.
|
Text
bLST_2019_deVriesJF.pdf Download (647kB) | Preview |
|
![[img]](https://fse.studenttheses.ub.rug.nl/style/images/fileicons/text.png) |
Text
toestemming.pdf Restricted to Registered users only Download (233kB) |
Abstract
Staphylococcus aureus (S. aureus) is a common and a frequent virulent pathogen in humans. S. aureus, a ubiquitous bacterium among humans, can cause severe infections such as cellulitis, sepsis and osteomyelitis. The emergence of antibiotics in the 1940s led to believe that bacterial infections would cease to exist. In 1959, however, bacteria started to gain resistance to antibiotics, including S. aureus. Despite the many attempts of developing new antibiotics, bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) were unaffected. This has led to a renewed interest in phage therapy, a non-antibiotic approach to treat bacterial infections. Here, I will give an overview of the current state of S. aureus phage therapy.
| Item Type: | Thesis (Bachelor's Thesis) |
|---|---|
| Supervisor name: | Buist, G. |
| Degree programme: | Life Science and Technology |
| Thesis type: | Bachelor's Thesis |
| Language: | English |
| Date Deposited: | 12 Aug 2019 |
| Last Modified: | 28 Aug 2019 10:08 |
| URI: | https://fse.studenttheses.ub.rug.nl/id/eprint/20647 |
Actions (login required)
 |
View Item |